Scientists have used large scale
super-computer simulations to discover a new class of drugs that may combat
antibiotic resistance on disease causing bacteria. Laboratory experiments were
combined with super-computing modeling to identify molecules that boost the
effect of antibiotics on bacteria. Researchers, including those from University
of Oklahoma (OU) in the US, identified four new chemicals that seek out and disrupt
bacterial proteins called “efflux pumps”, a major cause of antibiotic
resistance in bacteria. The supercomputing power of Oak Ridge National
Laboratory’s Titan supercomputer allowed us to perform large scale simulations
of the drug targets and to screen many potential compounds quickly. The information
researchers received was combined with their experiments to select molecules
that were found to work well, and this should drastically reduce the time
needed to move from the experimental phase to clinical trials.
No comments:
Post a Comment